Stefania Faletti

7PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)GenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 10, 2026
Vitamin D binding protein induces skeletal muscle atrophy and contributes to cancer-associated muscle wasting independently of vitamin D status in preclinical models.

Tommaso Raiteri, Simone Reano, Andrea Scircoli

|May 23, 2025
Metabolic traits shape responses to LSD1-directed therapy in glioblastoma tumor-initiating cells.

|Nov 26, 2024
Morphoregulatory ADD3 underlies glioblastoma growth and formation of tumor-tumor connections.

Carlotta Barelli, Flaminia Kaluthantrige Don, Raffaele M Iannuzzi

|Jun 29, 2023
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation.

Annamaria Antona, Giovanni Leo, Francesco Favero

|Nov 22, 2022
ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma.

Roberto Ferrarese, Annalisa Izzo, Geoffroy Andrieux

|Dec 08, 2021
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response.

Stefania Faletti, Daniela Osti, Elena Ceccacci

Pageof 2

Frequent Collaborators

2 joint publications

Cristina Richichi

2 joint publications

Roberta Noberini

2 joint publications

Giulia Marotta

2 joint publications

Giuliana Pelicci